India·Source-based summary

Study attempts to find out howIndia made expensive diabetes medicines affordable

India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists

This is a source-based summary, not original reporting by Ebenezer journalists. Source: The Hindu. Ebenezer published 19 Sept 2026, 04:23 pm. Editorial policy.

Read the original report on The Hindu
The Hindu19 Sept 2026, 04:23 pmUpdated 18h ago1 min readIndiaIndia
Study attempts to find out how India made expensive diabetes medicines affordable

IndiaThe Hindu

India’s low medication prices are tied to its role as a major pharmaceutical exporter, supported by legislation that prevents ‘patent evergreening’ and enables generic drug manufacturing, says a study by diabetologists

This report is published with credit to The Hindu. The wire sent a summary; open the original for any extra context. Read on The Hindu

Source: The Hindu. Published 19 Sept 2026, 04:23 pm.

Keep reading

Back to the desk
info@ebenezerdigital.com+91 98944 96560WhatsApp

Privacy · Terms · Sitemap